Clinical Research: Phase 1 - Phase 4
Premier Insight 265: Complete Response: Lymphoma Trial A Surprising Success For Five Patients
A trans-Atlantic study to evaluate an antibody for treatment of B-cell non-Hodgkins lymphoma is still almost three years from completing patient follow-up, but already it has succeeded beyond expectations in the form of five patients declared disease-free a year and counting. The Phase 2 trial involved a CD19 antibody that was tested at 26 sites...